These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3179461)

  • 1. Quality control of hemoglobin-based blood substitutes.
    Hsia JC; Er SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):105-11. PubMed ID: 3179461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and partial characterization of pyridoxal 5'-phosphate hemoglobins by high-performance liquid chromatography as a quality-control method for hemoglobin-based blood substitutes.
    McGarrity MJ; Er SS; Nightingale KA; Hsia JC
    J Chromatogr; 1987 Jan; 413():53-63. PubMed ID: 3558695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine tuning of polymerized pyridoxylated hemoglobin as a red blood cell substitute.
    Hsia CJ
    Prog Clin Biol Res; 1989; 319():339-49. PubMed ID: 2622918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible importance of chromatographic purification position in a blood substitute elaboration process.
    Menu P; Faivre B; Labrude P; Grandgeorge M; Vigneron C
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):443-5. PubMed ID: 1391461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and physical characteristics of a hemoglobin solution modified by coupling to 2-nor-2-formylpyridoxal 5'-phosphate (NFPLP).
    van der Plas J; de Vries-Van Rossen A; Koorevaar JJ; Buursma A; Zijlstra WG; Bakker JC
    Transfusion; 1988; 28(6):525-30. PubMed ID: 2461607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The structuro-functional heterogeneity of an artificial oxygen carrier based on hemoglobin].
    Viazova EP; Azhigirova MA; Fetisova LV; Shuvalova AL; Zeĭnalov AI
    Biull Eksp Biol Med; 1990 Mar; 109(3):254-6. PubMed ID: 2364151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced coronary vasoconstrictor activity of hemoglobin solutions purified by ATP-agarose affinity chromatography.
    Vogel WM; Hsia JC; Briggs LL; Er SS; Cassidy G; Apstein CS; Valeri CR
    Life Sci; 1987 Jul; 41(1):89-93. PubMed ID: 3600177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the quality control of stroma-free hemoglobin.
    Sekiguchi S
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):407-14. PubMed ID: 1391456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conceptual design and cost estimate for a modified hemoglobin production plant.
    Jin CK; Owings D
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):463-70. PubMed ID: 1391465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of purification on transfusional efficacy of hemoglobin solutions.
    Menu P; Labrude P; Grandgeorge M; Vigneron C
    Int J Artif Organs; 1991 Oct; 14(10):672-5. PubMed ID: 1748536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A natural compound (reuterin) produced by Lactobacillus reuteri for hemoglobin polymerization as a blood substitute.
    Chen YC; Chang WH; Chang Y; Huang CM; Sung HW
    Biotechnol Bioeng; 2004 Jul; 87(1):34-42. PubMed ID: 15211486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot scale production of pyrogen-free human hemoglobin for research.
    Chapman KW; Snell SM; Jesse RG; Morano JK; Everse J; Winslow RM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):415-21. PubMed ID: 1391457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stroma-free hemoglobin solutions on isolated perfused rabbit hearts and isolated perfused rat kidneys.
    Vogel WM; Lieberthal W; Apstein CS; Levinsky N; Valeri CR
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):227-35. PubMed ID: 3140918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier.
    Yabuki A; Yamaji K; Ohki H; Iwashita Y
    Transfusion; 1990; 30(6):516-20. PubMed ID: 2378023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of analytical methods to evaluate SFH.
    Nakai K; Abe H; Matsuda N; Kobayashi M; Ikeda H; Sekiguchi S; Tsuchida E
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):447-51. PubMed ID: 1391462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physico-chemical and pharmacological comparison of pyridoxylated hemoglobin bound to polyoxyethylene or polymerized by glutaraldehyde.
    Menu P; Mouelle P; Clerc Y; Labrude P; Vigneron C
    Int J Artif Organs; 1991 Dec; 14(12):805-9. PubMed ID: 1783456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polyhemoglobin-based model of an artificial oxygen carrier with functional properties similar to blood].
    Khachatur'ian AA; Shlimak VM; Azhigirova MA; Viazova EP; Zeĭnalov AM
    Biull Eksp Biol Med; 1981 Mar; 91(3):311-3. PubMed ID: 7248504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-encapsulated hemoglobin processing methods.
    Zheng S; Zheng Y; Beissinger RL; Fresco R
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):355-64. PubMed ID: 1391451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acellular and cellular hemoglobin solutions as vasoconstrictive factor.
    Nakai K; Matsuda N; Amano M; Ohta T; Tokuyama S; Akama K; Kawakami Y; Tsuchida E; Sekiguchi S
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):559-64. PubMed ID: 7527722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of virus-free pyridoxylated hemoglobin from the blood of HBV or HTLV-I healthy carriers.
    Sekiguchi S; Ito K; Kobayashi M; Ototake N; Kosuda M; Kwon KW; Ikeda H
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):113-21. PubMed ID: 3179462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.